OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation

IT Archived • December 15, 2025 •

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

Source: https://techcrunch.com/feed/ - Read Original

"We build AI or anything ICST"

FB X ✉️

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!